1. Home
  2. UNTY vs INBX Comparison

UNTY vs INBX Comparison

Compare UNTY & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$56.14

Market Cap

507.4M

Sector

Finance

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$86.80

Market Cap

430.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
INBX
Founded
1991
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
507.4M
430.2M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
UNTY
INBX
Price
$56.14
$86.80
Analyst Decision
Buy
Hold
Analyst Count
3
2
Target Price
$59.67
N/A
AVG Volume (30 Days)
37.5K
232.9K
Earning Date
01-14-2026
11-14-2025
Dividend Yield
1.06%
N/A
EPS Growth
35.12
N/A
EPS
5.27
N/A
Revenue
$121,970,000.00
$1,400,000.00
Revenue This Year
$24.41
$563.00
Revenue Next Year
$11.16
$230.77
P/E Ratio
$10.69
N/A
Revenue Growth
20.98
N/A
52 Week Low
$36.65
$10.81
52 Week High
$57.24
$94.47

Technical Indicators

Market Signals
Indicator
UNTY
INBX
Relative Strength Index (RSI) 75.28 59.17
Support Level $55.35 $74.80
Resistance Level $57.24 $94.47
Average True Range (ATR) 1.76 6.36
MACD 0.33 -1.27
Stochastic Oscillator 86.16 62.68

Price Performance

Historical Comparison
UNTY
INBX

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: